E.L. Ramos, C.M. Dayan, L. Chatenoud, Z. Sumnik, K.M. Simmons, A. Szypowska, S.E. Gitelman, L.A. Knecht, E. Niemoeller, W. Tian, K.C. Herold, PROTECT study investigators. Teplizumab and β-cell function in newly diagnosed type 1 diabetes. N. Engl. J. Med 389(23), 2151–2161 (2023). https://doi.org/10.1056/NEJMoa2308743

Article  PubMed  CAS  Google Scholar 

J. Weng, Z. Zhou, L. Guo, D. Zhu, L. Ji, X. Luo, Y. Mu, W. Jia, T1D China Study Group. Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ 360, j5295 (2018). https://doi.org/10.1136/bmj.j5295

Article  PubMed  PubMed Central  Google Scholar 

X. Tang, X. Yan, H. Zhou, X. Yang, X. Niu, J. Liu, Q. Ji, L. Ji, X. Li, Z. Zhou, Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes. Diab. Metab. Syndr. Obes. 12, 1527–1541 (2019). https://doi.org/10.2147/DMSO.S202193

Article  CAS  Google Scholar 

A. Janež, C. Guja, A. Mitrakou, N. Lalic, T. Tankova, L. Czupryniak, A.G. Tabák, M. Prazny, E. Martinka, L. Smircic-Duvnjak, Insulin therapy in adults with type 1 diabetes mellitus: a narrative review. Diab. Ther. 11(2), 387–409 (2020). https://doi.org/10.1007/s13300-019-00743-7

Article  Google Scholar 

I. Avgerinos, A. Manolopoulos, T. Michailidis, K. Kitsios, A. Liakos, T. Karagiannis, K. Dimitrakopoulos, D.R. Matthews, A. Tsapas, E. Bekiari, Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: a systematic review and network meta-analysis. Diab. Obes. Metab. 23(3), 822–831 (2021). https://doi.org/10.1111/dom.14291

Article  CAS  Google Scholar 

A. Sheikhy, Z. Eydian, A. Fallahzadeh, M. Shakiba, M. Hajipour, M. Alaei, A. Mosallanejad, H. Saneifard, Benefits of metformin add-on insulin therapy (MAIT) for HbA1c and lipid profile in adolescents with type 1 diabetes mellitus: preliminary report from a double-blinded, placebo-controlled, randomized clinical trial. J. Pediatr. Endocrinol. Metab. 35(4), 505–510 (2022). https://doi.org/10.1515/jpem-2021-0704

Article  PubMed  CAS  Google Scholar 

M. Durán-Martínez, S. Azriel, V.K. Doulatram-Gamgaram, Ó. Moreno-Pérez, P.J. Pinés-Corrales, C. Tejera-Pérez, J.F. Merino-Torres, M. Brito-Sanfiel, A. Chico, A. Marco, E. García-Fernández, J.I. Martínez-Montoro; Diabetes Area of the Spanish Society of Endocrinology and Nutrition (SEEN), Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study. Diab. Metab. 50(1), 101501 (2024). https://doi.org/10.1016/j.diabet.2023.101501

Article  CAS  Google Scholar 

X. Zhang, D. Xu, P. Xu, S. Yang, Q. Zhang, Y. Wu, F. Yuan, Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial. Endocr. Connect 10(9), 1045–1054 (2021). https://doi.org/10.1530/EC-21-0146

Article  PubMed  PubMed Central  CAS  Google Scholar 

K.V. Hari Kumar, A. Shaikh, P. Prusty, Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study. Diab. Res Clin. Pract. 100(2), e55–e58 (2013). https://doi.org/10.1016/j.diabres.2013.01.020

Article  CAS  Google Scholar 

L. Qiu, P. Ling, D. Yang, S. Luo, X. Zheng, H. Liang, Y. Yuan, G. Liang, W. Xu, B. Yao, J. Yan, J. Weng, Current status of metformin in addition to insulin therapy in adult patients with type 1 diabetes mellitus: An analysis from the Guangdong Type 1 Diabetes Mellitus Translational Medicine Study. J. Diab. 12(10), 754–760 (2020). https://doi.org/10.1111/1753-0407.13025

Article  CAS  Google Scholar 

World Medical Association, World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191–2194 (2013). https://doi.org/10.1001/JAMA.2013.281053

Article  Google Scholar 

American Diabetes Association Professional Practice Committee, 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diab. Care 45(1), S17–S38 (2022). https://doi.org/10.2337/dc22-S002

Article  Google Scholar 

F. Li, K.L. Morgan, A.M. Zaslavsky, Balancing covariates via propensity score weighting. J. Am. Stat. Assoc. 113, 390–400 (2018)

Article  CAS  Google Scholar 

Z. Zhang, H.J. Kim, G. Lonjon, Y. Zhu, Balance diagnostics after propensity score matching. Ann. Transl. Med 7, 16 (2019). https://doi.org/10.21037/atm.2018.12.10

Article  PubMed  PubMed Central  CAS  Google Scholar 

W. Wang, F. Huang, C. Han, Efficacy of regimens in the treatment of latent autoimmune diabetes in adults: a network meta-analysis. Diab. Ther. 14(10), 1723–1752 (2023). https://doi.org/10.1007/s13300-023-01459-5

Article  CAS  Google Scholar 

T. Lin, Y. Cai, L. Tang, Y. Lian, M. Liu, C. Liu, Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta-analysis. J. Diab. Investig. 13(9), 1506–1519 (2022). https://doi.org/10.1111/jdi.13814

Article  CAS  Google Scholar 

I.M. Libman, K.M. Miller, L.A. DiMeglio, K.E. Bethin, M.L. Katz, A. Shah, J.H. Simmons, M.J. Haller, S. Raman, W.V. Tamborlane, J.K. Coffey, A.M. Saenz, R.W. Beck, K.J. Nadeau, T1D exchange clinic network metformin RCT study group. Effect of metformin added to insulin on glycemic control among overweight/obese adolescents with type 1 diabetes: a randomized clinical trial. JAMA 314(21), 2241–2250 (2015). https://doi.org/10.1001/jama.2015.16174

Article  PubMed  CAS  Google Scholar 

Q. Wang, M. Long, H. Qu, R. Shen, R. Zhang, J. Xu, X. Xiong, H. Wang, H. Zheng, DPP-4 inhibitors as treatments for type 1 diabetes mellitus: a systematic review and meta-analysis. J. Diab. Res 2018, 5308582 (2018). https://doi.org/10.1155/2018/5308582

Article  CAS  Google Scholar 

F. Aberer, T.R. Pieber, M.L. Eckstein, H. Sourij, O. Moser, Glucose-lowering therapy beyond insulin in type 1 diabetes: a narrative review on existing evidence from randomized controlled trials and clinical perspective. Pharmaceutics 14(6), 1180 (2022). https://doi.org/10.3390/pharmaceutics14061180

Article  PubMed  PubMed Central  CAS  Google Scholar 

Y. Xie, M. Shi, X. Ji, F. Huang, L. Fan, X. Li, Z. Zhou, Insulin resistance is more frequent in type 1 diabetes patients with long disease duration. Diab. Metab. Res. Rev. 39(Sep 6), e3640 (2023). https://doi.org/10.1002/dmrr.3640

Article  CAS  Google Scholar 

L. Xu, W. Wang, W. Song, A combination of metformin and insulin improve cardiovascular and cerebrovascular risk factors in individuals with type 1 diabetes mellitus. Diab. Res Clin. Pract. 191, 110073 (2022). https://doi.org/10.1016/j.diabres.2022.110073

Article  CAS  Google Scholar 

W. Wang, Y. Gao, D. Chen, C. Wang, X. Feng, X. Ran, Efficacy and safety of incretin-based drugs in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Diab. Res Clin. Pract. 129, 213–223 (2017). https://doi.org/10.1016/j.diabres.2017.05.007

Article  CAS  Google Scholar 

M.R. Rickels, C. Evans-Molina, H.T. Bahnson, A. Ylescupidez, K.J. Nadeau, W. Hao, M.A. Clements, J.L. Sherr, R.E. Pratley, T.S. Hannon, V.N. Shah, K.M. Miller, C.J. Greenbaum, T1D exchange β-cell function study group. High residual C-peptide likely contributes to glycemic control in type 1 diabetes. J. Clin. Invest 130(4), 1850–1862 (2020). https://doi.org/10.1172/JCI134057

Article  PubMed  PubMed Central  CAS  Google Scholar 

K.C. Herold, J. Reynolds, J. Dziura, D. Baidal, J. Gaglia, S.E. Gitelman, P.A. Gottlieb, J. Marks, L.H. Philipson, R. Pop-Busui, R.S. Weinstock, Exenatide extended release in patients with type 1 diabetes with and without residual insulin production. Diab. Obes. Metab. 22(11), 2045–2054 (2020). https://doi.org/10.1111/dom.14121

Article  CAS  Google Scholar 

F. Staels, C. Moyson, C. Mathieu, Metformin as add-on to intensive insulin therapy in type 1 diabetes mellitus. Diab. Obes. Metab. 19(10), 1463–1467 (2017). https://doi.org/10.1111/dom.12948

Article  CAS  Google Scholar 

A. Ziaee, N. Esmailzadehha, M. Honardoost, Comparison of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus. Pak. J. Med Sci. 33(3), 686–690 (2017). https://doi.org/10.12669/pjms.333.12669

Article  PubMed  PubMed Central  Google Scholar 

G. Riccardi, R. Giacco, M. Parillo, S. Turco, A.A. Rivellese, M.R. Ventura, S. Contadini, G. Marra, M. Monteduro, F. Santeusanio, P. Brunetti, M.C. Librenti, A.E. Pontiroli, P. Vedani, G. Pozza, L. Bergamini, C. Bianchi, Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study. Diabet. Med 16(3), 228–232 (1999). https://doi.org/10.1046/j.1464-5491.1999.00047.x

Article  PubMed  CAS  Google Scholar 

L. Liu, Z. Shao, Y. Xia, J. Qin, Y. Xiao, Z. Zhou, Z. Mei, Incretin-based therapies for patients with type 1 diabetes: a meta-analysis. Endocr. Connect 8(3), 277–288 (2019). https://doi.org/10.1530/EC-18-0546

Article  PubMed